Most patients begin experiencing appetite suppression within the first week, with many reporting reduced hunger as early as day 3 of their first dose
In September 2025, Regeneron reported interim Phase II COURAGE trial results showing that combining semaglutide with trevogrumab, with or without garetosmab, helped preserve lean mass and enhance fat loss in obesity treatment
If youre switching from Mounjaro or beginning treatment with Wegovy for the first time, youll need to follow a titration plan agreed with your clinician before becoming eligible for this higher dose - this will be on a case-by-case scenario
Remember, you are not alone in your health journey
Disclaimer: GLPeak is for tracking and educational purposes only
A shift like this would trickle down to improvements in commercial insurance coverage, placing pressure on other payers and potentially stimulating a reevaluation of coverage and restrictions across the board